Cigna Group $CI Stock Holdings Lifted by Levin Capital Strategies L.P.

Levin Capital Strategies L.P. raised its position in shares of Cigna Group (NYSE:CI) by 193.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,070 shares of the health services provider’s stock after purchasing an additional 4,000 shares during the period. Levin Capital Strategies L.P.’s holdings in Cigna Group were worth $1,750,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Norges Bank bought a new stake in Cigna Group in the second quarter worth approximately $1,110,426,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Cigna Group by 24.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares during the last quarter. Balyasny Asset Management L.P. boosted its holdings in Cigna Group by 1,057.2% in the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares in the last quarter. Man Group plc increased its position in Cigna Group by 215.5% during the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock worth $175,929,000 after buying an additional 363,510 shares during the last quarter. Finally, Corient Private Wealth LLC raised its holdings in Cigna Group by 257.4% during the second quarter. Corient Private Wealth LLC now owns 389,637 shares of the health services provider’s stock valued at $127,811,000 after buying an additional 280,616 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $290.24 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a fifty day moving average price of $278.52 and a 200 day moving average price of $283.99. The stock has a market cap of $77.53 billion, a P/E ratio of 13.09, a PEG ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Wells Fargo & Company decreased their price target on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 5th. The Goldman Sachs Group decreased their target price on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price target on shares of Cigna Group in a research report on Tuesday, January 6th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Finally, Robert W. Baird dropped their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.63.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.